GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about INN information from WHO
Product list
Target
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
---|---|---|---|---|---|---|
Pre-Made Cetrelimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Cetrelimab |
NA |
PDCD1/PD-1 |
Whole mAb |
||
Pre-Made Cetuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Cetuximab |
NA |
EGFR |
Whole mAb |
||
Pre-Made Cevostamab biosimilar, Bispecific mAb: Anti-FCRL5;CD3 therapeutic antibody |
Cevostamab |
NA |
FCRL5,CD3 |
Bispecific mAb |
||
Pre-Made Cibisatamab biosimilar, Bispecific mAb with Domain Crossover: Anti-CEACAM5;CD3E therapeutic antibody |
Cibisatamab |
NA |
CEACAM5,CD3E |
Bispecific mAb with Domain Crossover |
||
Pre-Made Cilgavimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody |
Cilgavimab |
NA |
SARS-CoV-2 Spike RBD |
Whole mAb |
||
Pre-Made Cinpanemab biosimilar, Whole mAb, Anti-SNCA Antibody: Anti-NACP/PARK1/PARK4/PD1 therapeutic antibody |
Cinpanemab |
NA |
SNCA |
Whole mAb |
||
Pre-Made Citatuzumab biosimilar, Fab Fusion, Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody |
Citatuzumab |
NA |
EPCAM |
Fab Fusion |
||
Pre-Made Cixutumumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody |
Cixutumumab |
NA |
IGF1R |
Whole mAb |
||
Pre-Made Claudiximab biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody |
Claudiximab |
zolbetuximab |
CLDN18 |
Whole mAb |
||
Pre-Made Clazakizumab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody |
Clazakizumab |
NA |
IL6 |
Whole mAb |
||
Pre-Made Clervonafusp biosimilar, di-Fab Fusion, Anti-SLC29A2/ENT2 Antibody: Anti-DER12/HNP36 therapeutic antibody |
Clervonafusp |
NA |
SLC29A2/ENT2 |
di-Fab Fusion |
||
Pre-Made Clivatuzumab biosimilar, Whole mAb Radiolabelled, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic ant |
Clivatuzumab |
NA |
MUC1 |
Whole mAb Radiolabelled |
||
Pre-Made Cobolimab biosimilar, Whole mAb, Anti-HAVCR2/TIM3 Antibody: Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2 therapeutic antibody |
Cobolimab |
NA |
HAVCR2/TIM3 |
Whole mAb |
||
Pre-Made Codrituzumab biosimilar, Whole mAb, Anti-GPC3 Antibody: Anti-DGSX/GTR2-2/MXR7/OCI-5/SDYS/SGB/SGBS/SGBS1 therapeutic antibody |
Codrituzumab |
NA |
GPC3 |
Whole mAb |
||
Pre-Made Cofetuzumab biosimilar, Whole mAb ADC, Anti-PTK7 Antibody: Anti-CCK-4/CCK4 therapeutic antibody |
Cofetuzumab |
NA |
PTK7 |
Whole mAb ADC |
||
Pre-Made Coltuximab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Coltuximab |
NA |
CD19 |
Whole mAb ADC |
||
Pre-Made Conatumumab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody |
Conatumumab |
NA |
TNFRSF10B/TRAIL-R2 |
Whole mAb |
||
Pre-Made Concizumab biosimilar, Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI therapeutic antibody |
Concizumab |
NA |
TFPI |
Whole mAb |
||
Pre-Made Coprelotamab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
Coprelotamab |
NA |
ERBB2/HER2 |
Whole mAb |
||
Pre-Made Cosfroviximab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody |
Cosfroviximab |
NA |
Zaire Ebolavirus GP |
Whole mAb |
||
Pre-Made Cosibelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Cosibelimab |
NA |
CD274/PD-L1 |
Whole mAb |
||
Pre-Made Crenezumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody |
Crenezumab |
NA |
APP |
Whole mAb |
||
Pre-Made Crizanlizumab biosimilar, Whole mAb, Anti-SELP Antibody: Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL therapeutic antibody |
Crizanlizumab |
NA |
SELP |
Whole mAb |
||
Pre-Made Crotedumab biosimilar, Whole mAb, Anti-GCGR Antibody: Anti-GGR/GL-R/MVAH therapeutic antibody |
Crotedumab |
NA |
GCGR |
Whole mAb |
||
Pre-Made Crovalimab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody |
Crovalimab |
NA |
C5/CO5 |
Whole mAb |
||
Pre-Made Cudarolimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody |
Cudarolimab |
NA |
TNFRSF4/CD134 |
Whole mAb |
||
Pre-Made Cusatuzumab biosimilar, Whole mAb, Anti-CD70/CD27-L Antibody: Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A therapeutic antibody |
Cusatuzumab |
NA |
CD70/CD27-L |
Whole mAb |
||
Pre-Made Dacetuzumab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody |
Dacetuzumab |
NA |
CD40 |
Whole mAb |
||
Pre-Made Daclizumab biosimilar, Whole mAb, Anti-IL2RA Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody |
Daclizumab |
NA |
IL2RA |
Whole mAb |
||
Pre-Made Dafsolimab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody |
Dafsolimab |
NA |
CD3E |
Whole mAb |
||
Pre-Made Dalotuzumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody |
Dalotuzumab |
NA |
IGF1R |
Whole mAb |
||
Pre-Made Dapirolizumab biosimilar, Fab, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody |
Dapirolizumab |
NA |
CD40LG |
Fab |
||
Pre-Made Daratumumab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody |
Daratumumab |
NA |
CD38 |
Whole mAb |
||
Pre-Made Datopotamab biosimilar, Whole mAb, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody |
Datopotamab |
NA |
TACSTD2 |
Whole mAb |
||
Pre-Made Daxdilimab biosimilar, Whole mAb, Anti-LILRA4/ILT7 Antibody: Anti-CD85g therapeutic antibody |
Daxdilimab |
NA |
LILRA4/ILT7 |
Whole mAb |
||
Pre-Made Dectrekumab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody |
Dectrekumab |
NA |
IL13 |
Whole mAb |
||
Pre-Made Demcizumab biosimilar, Whole mAb, Anti-DLL4 Antibody: Anti-AOS6/delta4/hdelta2 therapeutic antibody |
Demcizumab |
NA |
DLL4 |
Whole mAb |
||
Pre-Made Demupitamab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Demupitamab |
NA |
EGFR |
Whole mAb |
||
Pre-Made Denintuzumab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody |
Denintuzumab |
NA |
CD19 |
Whole mAb ADC |
||
Pre-Made Denosumab biosimilar, Whole mAb, Anti-TNFSF11/ODF Antibody: Anti-OPGL/sCD254/OPTB2/RANKL/TNLG6B/TRANCE/hRANKL2 therapeutic antibody |
Denosumab |
NA |
TNFSF11/ODF |
Whole mAb |
||
Pre-Made Depatuxizumab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Depatuxizumab |
NA |
EGFR |
Whole mAb ADC |
||
Pre-Made Depemokimab biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody |
Depemokimab |
NA |
IL5 |
Whole mAb |
||
Pre-Made Derlotuximab biosimilar, Whole mAb Radiolabelled: Anti-DNA/H1 Complex therapeutic antibody |
Derlotuximab |
NA |
DNA/H1 Complex |
Whole mAb Radiolabelled |
||
Pre-Made Dezamizumab biosimilar, Whole mAb, Anti-APCS Antibody: Anti-HEL-S-92n/PTX2/SAP therapeutic antibody |
Dezamizumab |
NA |
APCS |
Whole mAb |
||
Pre-Made Dilpacimab biosimilar, Bispecific mAb, Anti-DLL4;VEGFA Antibody: Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1 therapeutic antibody |
Dilpacimab |
NA |
DLL4,VEGFA |
Bispecific mAb |
||
Pre-Made Dinutuximab biosimilar, Whole Mab: Anti-Ganglioside GD2 therapeutic antibody |
Dinutuximab |
NA |
Ganglioside GD2 |
Whole mAb |
||
Pre-Made Diridavumab biosimilar, Whole Mab: Anti-Influenza A HA2 therapeutic antibody |
Diridavumab |
NA |
Influenza A HA2 |
Whole mAb |
||
Pre-Made Disitamab biosimilar, Whole mAb ADC, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
Disitamab |
NA |
ERBB2 |
Whole mAb ADC |
||
Pre-Made Divozilimab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Divozilimab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Docaravimab biosimilar, Whole mAb (Mouse): Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-III therapeutic antibody |
Docaravimab |
NA |
Rabies Virus Strain ERA GP Ectodomain Epitope G-III |
Whole mAb (Mouse) |